Diamond Edge Ventures — Full Portfolio
18 tracked investments · listed companies and verified rows first
Licella is a developer of hydrothermal liquefaction technology that converts low-cost waste biomass into advanced biofuels, including sustainable aviation fuel (SAF), renewable diesel, and biomaterials.
BiotechCircular EconomyCleantechEnergyNorth Sydney, AU
Dr Len Humphreys(Executive Chairman)Professor Thomas Maschmeyer AO
iAM Marketplace is an online marketplace for additive manufacturing, offering materials such as filaments, photopolymers, and powders alongside hardware, accessories, certified pre-owned equipment, and related services and solutions.
Advanced ManufacturingB2B MarketplacesNew Materials
Co-investorsWest Hill Capital
BO Materials develops novel materials for industrial applications across trillion-dollar industries.
AI & Machine LearningDeep TechNew MaterialsSemiconductorsMassachusetts, US
Michael Segal(Executive Officer, Director)inAnvesh Gurijala(Executive Officer, Director)
BoardDavid Miller(Director)inDwight Poler(Director)Andrew Goldman(Director)
Co-investorsAccelr8ACVC PartnersClean Energy VentureClean Energy VenturesCollaborative FundGood Growth Capital+4 more
DigiLens develops waveguide optics and holographic display technology using a proprietary material set combined with inkjet printing and a holographic contact copy process.
Deep TechHardwareNew MaterialsSunnyvale, US
Jonathan Waldern(Director)inChristopher Pickett(Executive Officer, Director)Patrick Suel(Director)Robert Young(Director)Thorsten Alexander Kern(Director)
BoardJim Whims(Director)
Co-investorsAlsop Louie PartnersBold Capital PartnersNautilus Ventures Management Company (Us), LlcSony Ventures CorporationDolby Family VenturesMITSUBISHI CHEMICAL+1 more
Lingrove designs and manufactures Ekoa, a bio-based composite made from renewable flax and plant resins used as impact-resistant wall protection, wall coverings, ceilings, and millwork for hospitality, healthcare, senior living, and workplace interiors.
CleantechConstruction TechNew Materials
Joe Luttwak(Founder)
Co-investorsSnatched VenturesIndieBioSOSV
Eridan develops wireless communication solutions for robotics and physical AI systems to enable their broader deployment and utility.
AI & Machine LearningDeep TechHardwareIoTRoboticsSunnyvale, US
Co-investorsEvolution VC PartnersMonta Vista CapitalPage One VenturesSand Hill AngelsSilicon CatalystUnanimous Capital+2 more
Yokogawa Fluence Analytics develops patented process analytics and control technologies, including its ACOMP system for real-time polymer reaction monitoring and its ARGEN static light scattering instrument for biopolymer stability testing.
Advanced ManufacturingAI & Machine LearningBiotechHardwareIoT
Co-investorsEnergy Innovation CapitalMITSUBISHI CHEMICAL
Freshr Technologies develops active packaging technology designed to extend the shelf life of fresh food and reduce waste.
Circular EconomyCleantechFoodTechNew Materials
Dr. Mina Mekhail(Founder and CEO)
Co-investorsNàdarra Ventures
Lactips produces natural, biobased polymers derived from protein that are biodegradable and water-soluble, addressing microplastic pollution across industrial applications.
Circular EconomyCleantechNew MaterialsSaint-Paul-en-Jarez, FR
Co-investorsBlue Ocean Capital GroupBNP Paribas DéveloppementBpifranceDemeterGO CapitalSWEN Capital Partners
Lingrove designs and manufactures Ekoa, a bio-based composite material made from flax and plant resins used as wall protection, wall coverings, ceilings, and millwork for hospitality, healthcare, and workplace interiors, as well as automotive interior applications.
CleantechConstruction TechNew MaterialsSan Rafael, US
Joseph Luttwak(Executive Officer, Director)in
BoardTalley Goodson(Director)Thomas Crow(Director)Stephen P. Welker(Director)
Co-investorsBoro CapitalCool Climate CollectiveSoundboard Venture FundHelium-3 VenturesIndieBioLewis & Clark AgriFood+2 more
Myoridge develops serum-free cell culture media and optimization services for cell cultivation and regenerative medicine applications.
BiotechHealthtechMedical DevicesJapan, JP
Co-investorsBeyond Next VenturesKyoto University Innovation Capital
Outrun Therapeutics is a preclinical biotech developing small molecule E3 ligase inhibitors to stabilise tumour suppressor proteins for treating cancer and other diseases.
BiotechDeep TechDundee, GB
Satpal Virdee(Founder)
Co-investorsM VenturesMC Healthcare Ventures
PharmEnable applies AI to small molecule drug discovery, focusing on challenging and data-sparse biological targets that traditional methods struggle to address.
AI & Machine LearningBiotechDeep Tech
Hannah Sore(Founder)in
Co-investorsCambridge Angels groupMartlet CapitalMC Healthcare VenturesO2h VenturesParkwalk AdvisorsWren Capital
Prime Roots makes plant-based deli meats designed to match conventional meat in blind taste tests, using clean ingredients without nitrates or celery salt.
ConsumerFoodTech
Kimberlie Le(Founder)in
Co-investorsDnx VenturesPangaea Ventures Us Inc.PortfoliaSpiral Sun VenturesAlumni VenturesGaingels+7 more
QurAlis develops precision therapies for amyotrophic lateral sclerosis (ALS) and related neurodegenerative diseases by targeting specific disease-causing genetic drivers and molecular mechanisms.
BiotechDeep TechMedical DevicesCambridge, US
Kevin Eggan(Co-founder)inRoet(Co-founder)Woolf(Co-founder)Kasper Roet(Director, Executive Officer, Promoter)inShafique Virani(Executive Officer)inJason Brown(Mr. Brown is the Chief Financial Officer of the Issuer.)in
Co-investorsDroia VenturesMC Healthcare VenturesMission BiocapitalMitsui Global InvestmentSanofi VenturesSV Health Investors+7 more
Advanced ManufacturingCleantechGolden, US
Andrew Maxey(Executive Officer, Director)inAaron Parker(Executive Officer)inDaniel Flagg(Executive Officer)inSean Kline(Executive Officer)inShari Kennett(Director)J. Scott Pusey(Executive Officer)
Co-investorsAutodesk FoundationBeyond CapitalCircular Innovation FundHG VenturesNew Climate VenturesRockies Venture Club+6 more
Other
Tracked investments with no reachable website or further public details — typically companies that wound down, renamed, or were absorbed.
DAIZTRIMTECH Therapeutics
Rows marked “SEC filing” are inferred from directors named on the company's SEC Form D — public regulatory data, not a portfolio list published by the firm.









































__Twitter.png)

















